Heartflow (HTFL) announced that it has filed a patent infringement lawsuit against Cleerly in the United States District Court for the Eastern District of Texas. The complaint seeks permanent injunctive relief and damages arising from Cleerly’s unauthorized and continued use of Heartflow’s patented technology. Heartflow asserts that Cleerly’s Ischemia, Plaque Analysis, and Compare products infringe six of Heartflow’s patents with priority dates from 2012 to 2018, protecting Heartflow innovations developed years before the introduction of any Cleerly product.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HTFL:
- Heartflow price target lowered to $35 from $40 at JPMorgan
- HeartFlow: Strong Q4 Beat, Conservative 2026 Guide, and Multiple High-Margin Growth Catalysts Support Buy Rating
- Heartflow price target raised to $43 from $40 at Canaccord
- Closing Bell Movers: Micron down 4% despite above-consensus and record Q2
- Heartflow reports Q4 EPS (29c), consensus (16c)